Belluscura LLC
$20.0K 1 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Core Surgical Group
Core Surgical Group reported $20,043.35 across General Payments, Research, and Ownership to 164 physicians and teaching hospitals across 164 transactions.
- $20.0K Below-median payer
- All-tracks total
- 164 Above-median volume
- Transactions
- 164 Above-median reach
- Recipients
- +$11.4K
- General Payments vs PY2023
Core Surgical Group reported $20,043.35 across all CMS Open Payments tracks (General + Research + Ownership) to 164 physicians and teaching hospitals in Program Year 2024 - ranking #1532 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $20,043.35, averaging $122.22 per recipient.
Core Surgical Group's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
10/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer core-surgical-group Core Surgical Group
$20.0K · #1532/1,925 · 0.0% industry · PY2024
- TOT $20.0K
- RANK #1532
- SHARE 0.0%
- TXN 164
- RCP 164
- CAT 2
- GEN $20.0K
- ΔGEN +$11.4K
- TOP1 5.5%
- PY 2024
Volume peers
Nearest volume peer: Belluscura LLC ($20.0K)
Core Surgical Group sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Core Surgical Group's CMS-reported General Payments increased by $11.4K (+131.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: CORE SURGICAL GROUPPY2024: Core Surgical Group. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $8,669.34
- PY2024
- $20,043.35
What the Data Shows for Core Surgical Group
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Core Surgical Group that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
"Food and Beverage" leads the 2-category general-payment breakdown below at $10.0K (50.1% of General Payments, 142 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Core Surgical Group made 2 types of general payments. "Food and Beverage" is the largest category at $10.0K, 50.1% of General Payments.
How Core Surgical Group divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $10.0K | 142 | 50.1% |
| Travel and Lodging | $10.0K | 22 | 49.9% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $4,530.95 (22.6%) of $20,043.35 in this company's General Payments records across 89 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Core Surgical Group
The five named recipients with the highest reported General Payments from this company
- 1
Tammy Noel
$1,109.60 across 3 reported transactions
- 2
Blake Turvey
$919.06 across 6 reported transactions
- 3
Sara Yancovitz
$894.61 across 4 reported transactions
- 4
Arturo Villarreal
$808.14 across 5 reported transactions
- 5
Claire Ryan
$799.54 across 6 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Core Surgical Group's spend rank (#1532 of 1,925, bottom 20% by spend) and concentration rank (#1,502 of 1,838, bottom 18% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Escala Medical Inc. : $6.0K total payments, HHI 266
- Elucent Medical : $251.3K total payments, HHI 265
- AltaThera Pharmaceuticals LLC : $230.3K total payments, HHI 265
- Team 1, Llc : $78.3K total payments, HHI 263
- ConvaTec Inc. : $8.5M total payments, HHI 261
- Avita Medical Americas, Llc : $545.0K total payments, HHI 257
- Core Surgical Group (this company) : $20.0K total payments, HHI 256
- Curonix LLC : $754.8K total payments, HHI 254
- Argon Medical Devices, Inc. : $147.3K total payments, HHI 254
- Averitas Pharma Inc. : $1.5M total payments, HHI 253
- Ambu A/S : $181.1K total payments, HHI 252
- Ivoclar Vivadent, Inc. : $280.4K total payments, HHI 251
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Core Surgical Group's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Core Surgical Group.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Core Surgical Group.
Showing 6 of 1,924 companies with CMS-reported payment data.
OTU Medical Inc.
$20.0K 2 recipients
Compare payment profiles
Gentleman Orthopedic Solutions
$20.0K 136 recipients
Compare payment profiles
DentalEZ, Inc.
$20.1K 39 recipients
Compare payment profiles
Medicomp Inc
$19.9K 746 recipients
Compare payment profiles
Virtus Pharmaceuticals LLC
$19.8K 987 recipients
Compare payment profiles
Put this to use
Core Surgical Group ranks #1532 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Core Surgical Group. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.